Rivio (Enterprise Systems (Healthcare)) key facts
as of Oct 2026- Developer of an AI-powered financial management platform designed to help healthcare organizations.
- Rivio (Enterprise Systems (Healthcare)) is valued at approximately $93.0M as of Oct 2026 (last reported valuation).
- It has raised $18.6M; the latest was Early Stage VC ($18.6M) in Dec 2025.
- Notable investors include Valor Capital Group, Monashees, Catarinense Technology Association, Endeavor Promessas.
- Status: Privately Held (backing).
Rivio (Enterprise Systems (Healthcare))'s last reported valuation, Dec 2025. Nothing priced has surfaced since.
- ·Watch Rivio (Enterprise Systems (Healthcare)): the Monday email on marks, rounds and moves
Rivio (Enterprise Systems (Healthcare)) funding rounds
No funding rounds for Rivio (Enterprise Systems (Healthcare)) are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
Who backs Rivio (Enterprise Systems (Healthcare))
4Rivio (Enterprise Systems (Healthcare)) valuation
Rivio (Enterprise Systems (Healthcare))'s last reported valuation was $93 million in Dec 2025. No priced round, secondary trade or fund mark has surfaced since.
Rivio (Enterprise Systems (Healthcare)) investors
4 investors are on record for Rivio (Enterprise Systems (Healthcare)), including Valor Capital Group, Monashees, Catarinense Technology Association and Endeavor Promessas.
About Rivio (Enterprise Systems (Healthcare))
Developer of an AI-powered financial management platform designed to help healthcare organizations. The company's platform offers features such as AI-reviewed medical bills, audit, automatic XML submission, financial control, enabling hospitals to manage bureaucratic processes, piles of paperwork, and administrative disputes in a simplified way.
- Sector
- Healthcare
- HQ
- Sao Paulo, Brazil
- Founded
- 2025
- Employees
- 42
- Website
- rivio.com.br/
- Ownership
- Privately Held (backing)
Is this your company? Sign in with your work email to keep it current, or tell us what's wrong.